Home
>
National Drug Code (NDC)
>
Nexiclon
Nexiclon - 27808-030-01 - (Clonidine)
Drug Information of Nexiclon
| Product NDC: | 27808-030 |
| Proprietary Name: | Nexiclon |
| Non Proprietary Name: | Clonidine |
| Active Ingredient(s): | .17 mg/1 & nbsp; Clonidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nexiclon
| Product NDC: | 27808-030 |
| Labeler Name: | Tris Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022500 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101217 |
Package Information of Nexiclon
| Package NDC: | 27808-030-01 |
| Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (27808-030-01) |
NDC Information of Nexiclon
| NDC Code | 27808-030-01 |
| Proprietary Name | Nexiclon |
| Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (27808-030-01) |
| Product NDC | 27808-030 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clonidine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101217 |
| Marketing Category Name | NDA |
| Labeler Name | Tris Pharma, Inc. |
| Substance Name | CLONIDINE |
| Strength Number | .17 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
